Brief: Xenitra Says Acquisition Of Fukang Otc Pharmacy
15/04/2026 02:51
April 15 (Reuters) - Xenitra XEN.AX: ACQUISITION OF FUKANG OTC PHARMACY HAS NOW AQUIRED 100% OF SHARES IN FUKANG + REQUIRED ASSETS TO OPERATE OTC MEDICINES BUSINESS TOTAL COST FOR ACQUISITION IS ¥469,243 Further company coverage: XEN.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xenitra
See all newsBrief: Xenitra To Raise A$1.5 Million Via Placement Of 500 Million Shares At A$0.003 Each
Brief: Xenitra Seeks Trading Halt For Material Capital Raising
Brief: Xenitra Announces A$12M Offtake Agreement With Leading OTC-Pharmaceutical
Brief: Xenitra Says OPAL RWA-Tokenised Product Sales Eclipse A$1 MLN In Just 7 Weeks
Brief: Xenitra Ltd Says It Will Raise A$1.25 Million Via Placement